Paula A Price
CIK 1369240 · Chief Financial Officer · last filed 2026-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ACN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WBD | Director | 0 | $30.95 | $0 | $0 | 12 | 2026-10-06 |
| ACN | Director | 8,561 | $255.53 | $2.19M | -$985.7K | 68 | 2026-08-17 |
| MDLZ | Director | 9,662 | $65.00 | $628.0K | $0 | 3 | 2026-05-21 |
| BMY | Director | — | $63.35 | — | $0 | 13 | 2026-02-03 |
| DVA | Director | 1,395 | $184.94 | $258.0K | -$184.4K | 9 | 2022-05-17 |
| WDC | Director | 7,545 | $356.40 | $2.69M | -$503.2K | 29 | 2022-02-01 |
| M | Chief Financial Officer | 2,010 | $24.02 | $48.3K | $25.3K | 3 | 2019-07-10 |
| DG | Director | 6,472 | $137.73 | $891.4K | $20.0K | 10 | 2018-05-31 |
| CHRS | Director | 0 | $1.04 | $0 | $0 | 3 | 2012-06-15 |
| CVS | Controller | 16,498 | $94.42 | $1.56M | $0 | 4 | 2008-02-14 |
Recent Filings · Page 15 of 16
155 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-16 | DG | Buy (P) | +267 | $20.0K | EDGAR |
| 2015-02-06 | ACN | Grant (A) | +2,098 | $0 | EDGAR |
| 2015-01-20 | WDC | Grant (A) | — | $0 | EDGAR |
| 2014-11-19 | ACN | Grant (A) | +28 | $0 | EDGAR |
| 2014-11-06 | WDC | Mixed | +2,225 | $0 | EDGAR |
| 2014-10-16 | WDC | Grant (A) | — | $0 | EDGAR |
| 2014-08-27 | DG | Grant (A) | +883 | $0 | EDGAR |
| 2014-07-08 | WDC | Grant (A) | +1,015 | $0 | EDGAR |
| 2012-06-15 | CHRS | U | −46,902 | -$344.7K | EDGAR |
| 2011-06-17 | CHRS | Grant (A) | +35,156 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.